Company file · UHS
Universal Health Services
Universal Health Services' revenue rose 9.7% in FY2025, to $17.4B, and net income rose 30.4% to $1.5B
Revenue rose 9.7% to $17.4B in FY2025, from $15.8B in FY2024. Net income rose 30.4% to $1.5B. Acute Care Hospital Services was the largest segment, at 57% of revenue.
Key facts
Universal Health Services (NYSE: UHS) reported revenue of $17.4B for fiscal 2025, the year ended Dec 31, 2025, up 9.7% from fiscal 2024. Net income was $1.5B, up 30.4%. In its latest 10-Q, for the quarter ended Sep 30, 2026, revenue was $4.7B, up 5.3% from the same quarter a year earlier, and net income was $309M. The largest piece by segment was Acute Care Hospital Services, at 57% of fiscal 2025 revenue. Sources: 10-K for fiscal 2025 (filed Feb 25, 2026) and 10-Q for the quarter ended Sep 30, 2026 (filed Nov 6, 2026).
Source: 10-K FY2025, filed Feb 25, 2026
Source: 10-Q filed May 7, 2026 · 10-Q filed Aug 7, 2026 · 10-Q filed Nov 6, 2026
How it makes money
By segment, FY2025
- LineAmountSharevs FY2024
- Acute Care Hospital Services$9.9B57%+11.0%
- Behavioral Health Services$7.4B43%+8.0%
Source: 10-K FY2025, XBRL breakdown
By segment in FY2025: Acute Care Hospital Services (57%) and Behavioral Health Services (43%), as shares of total revenue. Total revenue was $17.4B.
Source: 10-K FY2025
By product or service, FY2025
Share is of the FY2025 total; the last column is the change from FY2024.
Learn more: Revenue vs. net income · Gross, operating and net margin
What changed last quarter
Comparing Q3 2026 (Jul to Sep 2026) compared with Q3 2025 (Jul to Sep 2025)
Each pair of bars shows the dollar amount for both quarters. Longer bar, more money. Bars in a group share one scale.
Q3 2026Q3 2025
Company
Source: Universal Health Services 10-Q for the quarter ended Sep 30, 2026, filed Nov 6, 2026
By segment
Source: Universal Health Services 10-Q for the quarter ended Sep 30, 2026, filed Nov 6, 2026
The bull case and the bear case
The bull case
- Revenue rose 9.7% in FY2025 to $17.4B, from $15.8B a year earlier. 10-K, FY2025
- Net income rose 30.4% in FY2025 to $1.5B, from $1.1B. 10-K, FY2025
- Diluted shares fell 5.1% in FY2025, so each share represents a larger slice of profit. 10-K, FY2025
- Revenue in the quarter ended Sep 30, 2026 was $4.7B, up 5.3% on a year earlier. 10-Q, quarter ended Sep 30, 2026
The bear case
- Operating cash flow fell 9.8% in FY2025 to $1.9B. 10-K, FY2025
- Total debt rose 5.5% in FY2025 to $4.8B. 10-K, FY2025
- Net income in the quarter ended Sep 30, 2026 was $309M, down 17.2% on a year earlier. 10-Q, quarter ended Sep 30, 2026
- Other Non Patient Revenue revenue fell 9.3% in FY2025 to $1.1B. 10-K, FY2025
What optimists and skeptics tend to point to, each tied to a filing. Ticker Sage doesn't pick a side, and neither list is a reason to buy or sell.
What the company does
Universal Health Services is in the health care facilities industry, part of the health care sector. The SEC files it under Services-General Medical & Surgical Hospitals, Nec.
Universal Health Services reports 2 segments: Acute Care Hospital Services and Behavioral Health Services.
Its fiscal year ends in December; the latest, FY2025, ended Dec 31, 2025.
Source: 10-K, Item 1 Business
Risks common in this industry
These are general risks for companies in the health care facilities industry. They are not a summary of Universal Health Services’s own risk factors; for those, read Item 1A of its latest 10-K, linked below.
- RegulationApprovals, safety rules and government oversight shape what it can sell and how.
- Pricing and reimbursementPayers, insurers and governments influence what it can charge.
- CompetitionNew treatments, generics and rival products can take share.
- LitigationProduct liability and other legal claims can lead to costs.
- SupplyManufacturing and supplier problems can interrupt products.
Source: 10-K, Item 1A Risk Factors (the company's own list, in the company's words)
Three years of key numbers
Every number links to its filing; hover for the XBRL tag. A dash means the number isn't cleanly available, and we don't estimate it.
| US$ | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $14.3B | $15.8B | $17.4B |
| Net income | $718M | $1.1B | $1.5B |
| Operating cash flow | $1.3B | $2.1B | $1.9B |
| Cash & equivalents (year end) | $119M | $126M | $138M |
| Total debt (year end) | $4.9B | $4.5B | $4.8B |
| Diluted shares | 70M | 68M | 64M |
- Revenue: Total revenue for the fiscal year, as the company reports it on its income statement.
- Net income: Net income attributable to the company's shareholders, after all costs, interest and taxes.
- Operating cash flow: Cash the business brought in from its day-to-day operations during the year (cash flow statement).
- Cash & equivalents: Cash and short-term investments that count as cash equivalents on the balance sheet. Excludes longer-dated marketable securities.
- Total debt: The current part of long-term debt plus long-term debt, at carrying value.
- Diluted shares: Weighted average shares outstanding for the year, including the effect of options and stock awards.
Learn more: How to read an income statement · Earnings per share, basic and diluted · Free cash flow · How to read a balance sheet · Growth rate calculator · P/E calculator · Market cap calculator · Free cash flow calculator · Return on equity and assets calculator
Explainers for this page
- Segment reporting
- Net debt and net cash
- Debt-to-equity ratio
- The cash flow statement
- Risk factors (Item 1A)
- How to read a 10-K
- Asset impairments
Plain-English guides to terms this file uses, with real numbers from filings.
About these numbers
Recent filings
| Form | Filed | Period |
|---|---|---|
| 10-Q | Nov 6, 2026 | Sep 30, 2026 |
| 10-Q | Aug 7, 2026 | Jun 30, 2026 |
| 10-Q | May 7, 2026 | Mar 31, 2026 |
| DEF 14A | Apr 9, 2026 | May 20, 2026 |
| 10-K | Feb 25, 2026 | Dec 31, 2025 |
Learn more: 10-K vs. 10-Q vs. 8-K · Form 4 insider filings · Fiscal years and quarters
Common questions about Universal Health Services
How does Universal Health Services make money?
Universal Health Services's revenue was $17.4B in fiscal 2025. By segment in FY2025: Acute Care Hospital Services (57%) and Behavioral Health Services (43%), as shares of total revenue. Total revenue was $17.4B. Source: 10-K for fiscal 2025, filed Feb 25, 2026.
What was Universal Health Services's revenue in fiscal 2025?
$17.4B of revenue for the fiscal year ended Dec 31, 2025, up 9.7% from $15.8B in fiscal 2024. Fiscal 2023 was $14.3B. Source: 10-K for fiscal 2025, filed Feb 25, 2026.
Is Universal Health Services profitable?
Universal Health Services reported net income of $1.5B for fiscal 2025, up 30.4% from $1.1B in fiscal 2024. That is a profit under US accounting rules (GAAP). In the quarter ended Sep 30, 2026, net income was $309M. The page's About these numbers section explains what is included. Source: 10-K for fiscal 2025, filed Feb 25, 2026.
What did Universal Health Services report in its latest quarterly filing?
Revenue was $4.7B in the quarter ended Sep 30, 2026, up 5.3% from $4.5B a year earlier. Net income was $309M, down 17.2% from $373M. Source: 10-Q for the quarter ended Sep 30, 2026, filed Nov 6, 2026.
How much cash and debt does Universal Health Services have?
Universal Health Services had $169M in cash and cash equivalents and $5.7B of total debt on Sep 30, 2026. Total debt here is the current part of long-term debt plus long-term debt, at carrying value. Source: 10-Q filed Nov 6, 2026.
What are the main risks Universal Health Services faces?
Universal Health Services's own risk factors are in Item 1A of its 10-K for fiscal 2025, filed Feb 25, 2026. Risks that are common among companies in the health care facilities industry include Regulation; pricing and reimbursement; competition; litigation; supply. The first: Approvals, safety rules and government oversight shape what it can sell and how. Source: 10-K, Item 1A Risk Factors.
Where do these Universal Health Services numbers come from?
From Universal Health Services's own SEC filings: the 10-K for fiscal 2025 (filed Feb 25, 2026) and the 10-Q for the quarter ended Sep 30, 2026 (filed Nov 6, 2026), read through the SEC's public XBRL data. Each number on this page links to its filing. Methodology explains how fiscal years and missing numbers are handled.
Tracked funds that report owning Universal Health Services
- Millennium Management: 417,369 shares, reported value $62.1M at Jun 30, 2026 (−39.3% in shares since the filing for Mar 31, 2026). Form 13F filed Aug 14, 2026.
- Citadel Advisors: 308,147 shares, reported value $45.8M at Jun 30, 2026 (+274.9% in shares since the filing for Mar 31, 2026). Form 13F filed Sep 2, 2026.
- Bridgewater Associates: 228,121 shares, reported value $33.9M at Jun 30, 2026 (+67.3% in shares since the filing for Mar 31, 2026). Form 13F filed Aug 14, 2026.
- Point72 Asset Management: 41,363 shares, reported value $6.2M at Jun 30, 2026 (new in this filing). Form 13F filed Aug 14, 2026.
From each fund’s latest Form 13F, which is filed up to 45 days after quarter end and lists long positions in US-listed stocks only. A listing here is a fact about a filing, not a view on the stock. What a 13F does and doesn’t show.
Disclosures
- Editor holdings in UHS
- The editor holds no position in Universal Health Services (UHS). As of Nov 11, 2026.
- Trading rule
- The editor does not buy or sell UHS from 3 days before to 3 days after this page is published or substantively updated.
- Compensation
- Nobody paid for this page. No affiliate links on this page.
- Sources
- The company's SEC filings, linked next to each number or, for charts, in the source line under them.
- Last updated
- Nov 10, 2026
General education, the same for every reader. Not a recommendation to buy, sell or hold UHS, and it doesn't consider your situation.
Compare with peers
| Company | Fiscal year | Revenue | Revenue growth | Net income |
|---|---|---|---|---|
| Universal Health ServicesUHS | FY2025 | $17.4B | +9.7% | $1.5B |
| HCA HealthcareHCA | FY2025 | $75.6B | +7.1% | $6.8B |
| Eli LillyLLY | FY2025 | $65.2B | +44.7% | $20.6B |
| Johnson & JohnsonJNJ | FY2025 | $94.2B | +6.0% | $26.8B |
Each row is that company’s latest fiscal year from its own 10-K, using its own revenue and net income lines. Fiscal years end in different months, and line definitions differ (banks, insurers and oil companies count revenue differently), so this is a rough side-by-side, not a like-for-like comparison.
More company files
- ABBV AbbVie
- MRK Merck
- TMO Thermo Fisher
- AMGN Amgen
- GILD Gilead
- PFE Pfizer
- DHR Danaher
- BMY Bristol Myers Squibb
- VRTX Vertex Pharmaceuticals
- REGN Regeneron Pharmaceuticals
- MRNA Moderna
- VEEV Veeva Systems
- A Agilent Technologies
- WAT Waters
- IQV IQVIA
- ILMN Illumina
- BIIB Biogen
- MTD Mettler Toledo
- ZTS Zoetis
- INCY Incyte
- VTRS Viatris
- CRL Charles River Laboratories
- SOLV Solventum
- TECH Bio-Techne
- AAPL Apple
- MSFT Microsoft
- NVDA Nvidia
- AMZN Amazon
- GOOGL Alphabet
- META
New to filings? Learn has plain-English explainers and Tools has calculators. Methodology & Disclosures covers where every number comes from.